Clinical Trials on Herpes Simplex II

Total 4254 results

Shaman Pharmaceuticals

Completed

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

HIV Infections | Herpes Simplex

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) (MRSA)

Atopic Dermatitis | Methicillin-Resistant Staphylococcus Aureus | MRSA | Eczema Herpeticum

United States
Damascus University

Completed

The Use of an Esthetic Twin Block for Patients With Mandibular Retrusion

Class II Malocclusion

Syrian Arab Republic
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Herpes Zoster

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Herpes Zoster

Korea, Republic of
University of Tennessee
Merck Sharp & Dohme LLC; American Pharmacists Association

Completed

The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

Herpes Zoster

United States
Duke University

Completed

Partner-Assisted Emotional Disclosure for GI Cancer

Cancer of the GI System-stages II III and IV

United States
Meshalkin Research Institute of Pathology of Circulation

Unknown

Study of the AFB and Stenting of the Iliac Arteries

Aorta-iliac Segment Lesion (C,D Type by TASC II)

Russian Federation
Peking University Third Hospital

Recruiting

Electrical Phrenic Nerve Stimulation in Patients With VIDD

Diaphragms | Phrenic Nerves

China
Cairo University

Recruiting

Clinical Performance of Injection-Molding Vs. Incremental Packing of Resin Composite in Cavitated Posterior Teeth

Caries Class II

Egypt
Centre Hospitalier Universitaire de Nice

Completed

Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara

Epidermolysis Bullosa Simplex Dowling Meara

France
Loyola University

Not yet recruiting

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Shingles
University of Washington
Merck Sharp & Dohme LLC

Completed

Immune Response to Shingles Vaccination

Shingles

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Herpes Zoster | Shingles
Tulane University

Completed

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Fibrosis | Herpes Zoster
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Shingles
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

Shingles
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly

Shingles

United States
State University of New York at Buffalo

Completed

BRIUS Vs FFA Efficiency

Dental Malocclusion | Crowding, Tooth | Angle Class II | Angle Class I

United States
Dana-Farber Cancer Institute
MedWaves, Inc

Not yet recruiting

Avecure Flexible Microwave Ablation Probe For Lung Nodules

Lung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung Cancer

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
GlaxoSmithKline

Recruiting

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Herpes Zoster

Italy, Spain, United Kingdom, France
Jiangsu Rec-Biotechnology Co., Ltd.

Completed

The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)

Herpes Zoster

Philippines
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Persistence of Protection by Shingrix

Herpes Zoster

United States
Changchun BCHT Biotechnology Co.

Completed

Study on Efficacy of Attenuated Zoster Vaccine, Live

Herpes Zoster

China
Merck Sharp & Dohme LLC

Completed

A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)

Herpes Zoster
GlaxoSmithKline

Completed

Month 30 & 42 Extension Studies of CRD-004 Primary Study

Herpes Zoster

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)

Herpes Zoster
National Institute of Allergy and Infectious Diseases...

Completed

ZOSTAVAX® in Renal Transplant Patients

Herpes Zoster

United States
University Hospital, Ghent

Terminated

Nitrous Oxide - Sevoflurane-Remifentanil Interaction

ASA Class I/II Patients Scheduled for Surgery Under General Anesthesia

Belgium
Illumina, Inc.

Completed

Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA

Detection and Genotyping of Factor V and Factor II Point Mutations
Population Council
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; Ministry of Health, Thailand and other collaborators

Completed

Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

HIV Infections | Herpes Simplex | Syphilis | Trichomonas Vaginitis | Chlamydia Trachomatis | Neisseria Gonorrhoeae

Thailand
Microbio Co Ltd

Completed

Postbiotic MBS and Metformin Combination in Patients With T2DM

Type-II Diabetes

Taiwan
KeyBioscience AG
Eli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...

Terminated

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

Type II Diabetes Mellitus

Germany
GlaxoSmithKline

Completed

Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years

Herpes Zoster

China
Shanghai Institute Of Biological Products

Completed

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Herpes Zoster

China
Shanghai Institute Of Biological Products

Completed

A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults

Herpes Zoster

China
Merck Sharp & Dohme LLC

Completed

Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)

Herpes Zoster
Seoul National University Hospital

Completed

Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation

Herpes Zoster

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045)

Herpes Zoster
Beijing Chaoyang District Centre for Disease Control...

Completed

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)

Herpes Zoster
Merck Sharp & Dohme LLC

Withdrawn

A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

Herpes Zoster
GC Biopharma Corp

Not yet recruiting

An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years

Varicella Zoster Virus Infection
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Recruiting

Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus

Varicella

China
Green Cross Corporation

Recruiting

Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination

Varicella

Korea, Republic of
Shanghai Institute Of Biological Products

Completed

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Varicella

China
SK Bioscience Co., Ltd.

Completed

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

Varicella

Philippines

3

Subscribe